Federal officials say opioid-related deaths continue to decline in Canada, but they caution that the improvement is fragile and could be reversed without sustained action. The officials attribute the downturn to ongoing public health measures and harm-reduction efforts, including improved access to treatment and prevention supports, and continued monitoring of overdose risk. At the same time, they emphasize that opioid-related harms remain a serious problem and that vulnerable groups continue to face high risk. Federal representatives also indicate that changing drug supply conditions and fluctuations in local overdose trends can quickly affect mortality rates. In their view, maintaining momentum requires consistent funding and coordination across jurisdictions, as well as continued investment in evidence-based approaches such as safer supply initiatives where applicable, naloxone access, and expanded access to opioid agonist therapy. Officials stress that progress is measured over time and that short-term gains do not eliminate the need for long-term, system-wide strategies to reduce deaths and related harms.